Can methotrexate worsen symptoms of lung disease?
Yes. Methotrexate can cause lung problems, and those problems may worsen existing symptoms. The key concern is methotrexate-related lung injury, which can show up as a new or worsening shortness of breath, a persistent dry cough, chest discomfort, fever, or low oxygen levels. [1][2]
Because these symptoms overlap with many lung diseases (including interstitial lung disease and infections), worsening after starting or increasing methotrexate should be treated as potentially serious and evaluated promptly. [1][2]
Does methotrexate cause lung toxicity even if you already have lung disease?
It can. People with pre-existing lung conditions may be more vulnerable to serious respiratory side effects, and symptoms can worsen if methotrexate triggers lung inflammation or injury. The exact risk varies by patient and dose, but drug-induced lung disease is recognized as a known adverse effect. [1][2][3]
What types of lung problems can methotrexate cause?
The most important methotrexate-associated condition is drug-induced pneumonitis (a type of inflammatory lung injury). Symptoms often develop over weeks to months after starting methotrexate, but timing can vary. [1][2]
Methotrexate can also increase infection risk in some people (depending on the overall regimen and the underlying condition), and infections can worsen lung symptoms too. [3]
How soon after starting methotrexate can lung symptoms get worse?
Lung toxicity can occur after starting methotrexate, and it is often reported within the first year, but cases can happen at other times as well. [1][2] If symptoms worsen after a dose change or after starting the medication, that timing supports a clinical reassessment.
What should you do if breathing symptoms worsen on methotrexate?
Worsening cough, shortness of breath, fever, or new chest symptoms while taking methotrexate should be evaluated urgently, especially if you have underlying lung disease. Clinicians typically need to rule out infection and assess whether the pattern fits drug-induced pneumonitis. [1][2]
Management often involves stopping methotrexate and treating suspected drug-induced lung inflammation, but the right decision depends on the cause and severity. [1][2]
Can methotrexate “flare” rheumatoid lung disease or interstitial lung disease?
If you already have inflammatory lung disease, any drug-related lung toxicity can make symptoms worse, even if the underlying lung disease is stable. Because methotrexate pneumonitis and interstitial lung disease symptoms can look similar, worsening respiratory symptoms should not be assumed to be only a progression of the underlying condition. [1][2]
Are there specific risk factors that make lung side effects more likely?
Risk varies, but reported factors include older age and reduced lung reserve or existing lung disease; also higher cumulative exposure and certain comorbidities may increase concern. Clinicians weigh these factors when deciding whether methotrexate is appropriate and when monitoring. [1][2][3]
Do other drugs used with methotrexate affect lung symptoms?
Yes. Methotrexate is often used with other immune-modulating therapies, and those can change infection risk and complicate how lung symptoms are interpreted. If you are taking additional medications (especially other immunosuppressants), that can affect both risk and evaluation. [3]
---
Sources
[1] U.S. National Library of Medicine. Methotrexate (oral): warnings about lung problems (pneumonitis/shortness of breath, cough). https://medlineplus.gov/druginfo/meds/a682019.html
[2] FDA label information on methotrexate (lung injury/pneumonitis listed as a serious adverse reaction). https://www.accessdata.fda.gov/scripts/cder/daf/
[3] U.S. National Library of Medicine. Methotrexate: general drug information, including immune effects and serious infections. https://medlineplus.gov/druginfo/meds/a682019.html